Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Kuwait

Dar Al Dawa Records Solid Results

April 2006 | Company Finance Alert

Jordanian drugmaker Dar Al Dawa (DADI) recorded sales of JOD32.84mn (US$46.26mn) in 2005, with net income reaching JOD7.71mn (US$10.87mn), an increase of 7.27% compared to the same period last year. DADI is the second largest domestic drugmaker in Jordan, selling products in 22 countries in the MENA region and Europe. In order to boost revenues the company has embarked upon a number of projects in recent years.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Hikma On Upward Track

Companies / Kuwait Hikma's 2007 performance is being hailed as a success by industry observers. The company's full-year results for 2007 revealed that sales were up by a massive 41.6% on 2006, to US$448mn, while pre-tax...
March 2008
Hikma Bids For Local Rival

Companies / Kuwait In a move that would ensure its dominance of the local pharmaceutical market, Jordan's largest drugmaker Hikma has launched a JOD116mn (US$164mn) bid to acquire rival Arab Pharmaceutical Manufacturing...
October 2007
Steady Growth Expected In Kuwaiti Drug Sector

Companies / Kuwait The Kuwaiti pharmaceutical market can be expected to continue to grow steadily, if moderately, in the short term. Offsetting this expected growth is the government's cost-containment policy, which should...
May 2006
Hikma To Acquire Remaining Shares In JPI

Companies / Kuwait Jordanian drugmaker Hikma has announced that it is to acquire the 52.5% of its Saudi Arabian subsidiary Al Jazeera Pharmaceuticals Industries (JPI) that it does not already own, for SAR78.75 (US$20.93mn)....
April 2006
Hikma Announces Strong Sales

Companies / Kuwait Jordanian drugmaker Hikma has announced sales of US$262mn in 2005, an increase of 23.5% compared to the same period last year. Meanwhile profits reached US$135.8mn, up 25.2%. This strong performance...
April 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS